{
    "eid": "2-s2.0-85046663629",
    "title": "CAR T cell therapy for breast cancer: Harnessing the tumor milieu to drive T cell activation",
    "cover-date": "2018-05-10",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Breast cancer",
        "Chimeric antigen receptor",
        "Genetic engineering",
        "Inverted cytokine receptor",
        "T cell therapy"
    ],
    "authors": [
        "Pradip Bajgain",
        "Supannikar Tawinwung",
        "Lindsey D'Elia",
        "Sujita Sukumaran",
        "Norihiro Watanabe",
        "Valentina Hoyos",
        "Premal Lulla",
        "Malcolm K. Brenner",
        "Ann M. Leen",
        "Juan F. Vera"
    ],
    "citedby-count": 74,
    "ref-count": 58,
    "ref-list": [
        "Cancer statistics, 2017",
        "CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia",
        "Chimeric antigen receptor-modified T cells for acute lymphoid leukemia",
        "T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia",
        "Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia",
        "CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients",
        "Regulatory T cells increase in breast cancer and in stage IV breast cancer",
        "Regulatory T cells and breast cancer: implications for immunopathogenesis",
        "Myeloid-derived suppressor cells in breast cancer",
        "Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies",
        "Cytokine comparisons between women with breast cancer and women with a negative breast biopsy",
        "Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis",
        "Gene expression profiling of the tumor microenvironment during breast cancer progression",
        "IL4 primes the dynamics of breast Cancer progression via DUSP4 inhibition",
        "Lessons from immunology: IL4R directly promotes mammary tumor metastasis",
        "IL4 receptor alpha mediates enhanced glucose and glutamine metabolism to support breast cancer growth",
        "Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4",
        "Targeting IL4/IL4R for the treatment of epithelial cancer metastasis",
        "IL4 receptor ILR4alpha regulates metastatic colonization by mammary tumors through multiple signaling pathways",
        "Signaling from cytokine receptors that affect TH1 responses",
        "Regulation of innate CD8+ T-cell activation mediated by cytokines",
        "Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells",
        "An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas",
        "Tissue and serum MUC1 mucin detection in breast cancer patients",
        "A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells",
        "MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad",
        "MUC1 and metastatic cancer: expression, function and therapeutic targeting",
        "MUC1: a multifaceted oncoprotein with a key role in cancer progression",
        "Reversal of tumor immune inhibition using a chimeric cytokine receptor",
        "Improving chimeric antigen receptor-modified T cell function by reversing the immunosuppressive tumor microenvironment of pancreatic Cancer",
        "Fine-tuning the CAR spacer improves T-cell potency",
        "Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor",
        "Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2",
        "Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers",
        "Kinetics of tumor destruction by chimeric antigen receptor-modified T cells",
        "PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor",
        "Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients",
        "Optimizing the production of suspension cells using the G-rex \"M\" series",
        "APC-derived cytokines and T cell polarization in autoimmune inflammation",
        "Inflammatory cytokines as a third signal for T cell activation",
        "Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function",
        "Transplantation of anergic histoincompatible bone marrow allografts",
        "Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified anti-MUC1 chimeric antigen receptor transduced T cells",
        "CAR mechanics: driving T cells into the MUC of cancer",
        "Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling",
        "Engineered CAR T cells targeting the Cancer-associated Tn-Glycoform of the membrane mucin MUC1 control adenocarcinoma",
        "Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?",
        "IL-7: maintaining T-cell memory and achieving homeostasis",
        "Interleukin 7 is a T-cell growth factor",
        "Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7",
        "Chimeric antigen receptor T cells for sustained remissions in leukemia",
        "Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies",
        "Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy",
        "CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients",
        "The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9",
        "Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer",
        "Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice",
        "Over-expression of ST3Gal-I promotes mammary tumorigenesis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60008978",
            "affilname": "Texas Children's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008978",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60002441",
            "affilname": "Baylor College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002441",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "NIH-NCI",
        "Texas Children\u2019s Hospital Flow Cytometry Core Laboratory",
        "Texas Children\u2019s Hospital Small Animal Imaging Facility",
        "American Cancer Society",
        "Elsa U. Pardee Foundation",
        "V Foundation for Cancer Research",
        "Pancreatic Cancer Action Network",
        "National Pancreas Foundation",
        "Cancer Prevention and Research Institute of Texas",
        "Adrienne Helis Malvin Medical Research Foundation",
        "Baylor College of Medicine"
    ]
}